HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Treasury Shares (2016 - 2025)

HUTCHMED (China)'s (HMDCF) quarterly Treasury Shares came in at $15.4 million in Q4 2025, down 63.34% year-over-year from $42.1 million in Q4 2024, and down 63.34% quarter-over-quarter from $42.1 million in Q4 2024.

Analysis

HUTCHMED (China) (HMDCF) Treasury Shares (2016 - 2025) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Treasury Shares for 10 consecutive years, with $15.4 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Treasury Shares fell 63.34% year-over-year to $15.4 million in Q4 2025; TTM through Dec 2025 was $15.4 million, a 63.34% decrease from a year earlier, with the FY2025 full-year figure at $15.4 million, down 63.34% from the prior year.
  • Treasury Shares was $15.4 million for Q4 2025 at HUTCHMED (China), down from $42.1 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $42.1 million in Q4 2024 and troughed at $1.4 million in Q4 2021.
  • A 5-year average of $17.8 million and a median of $15.4 million in 2025 frame the typical range for Treasury Shares.
  • Across the five-year window, Treasury Shares sank 69.97% in 2021 and soared 729.93% in 2022, its largest moves.
  • Over 5 years, Treasury Shares stood at $1.4 million in 2021, then soared by 729.93% to $12.0 million in 2022, then surged by 50.81% to $18.1 million in 2023, then surged by 132.13% to $42.1 million in 2024, then tumbled by 63.34% to $15.4 million in 2025.
  • The last three Treasury Shares figures came in at $15.4 million (Q4 2025), $42.1 million (Q4 2024), and $18.1 million (Q4 2023), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Amgen 211.50 Bn 197.51 Bn 7.24 Bn -
2 Gilead Sciences 181.29 Bn 178.11 Bn 6.22 Bn -
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 82.55 Bn 74.56 Bn 3.93 Bn 36.40 Mn
5 Argenx Se 61.65 Bn 56.47 Bn 1.37 Bn -
6 Moderna 54.65 Bn 49.52 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 34.18 Bn 30.87 Bn 992.69 Mn -
8 Biogen 31.36 Bn 30.07 Bn 1.96 Bn -23.80 Mn
9 Roivant Sciences 30.01 Bn 30.01 Bn 1.16 Mn -
10 HUTCHMED (China) 376.85 Mn 391.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 15.44 Mn
Dec 31, 2025 15.44 Mn
Dec 31, 2024 42.13 Mn
Dec 31, 2024 42.13 Mn
Dec 31, 2023 18.15 Mn
Dec 31, 2023 18.15 Mn
Dec 31, 2022 12.03 Mn
Dec 31, 2022 12.03 Mn
Dec 31, 2021 1.45 Mn
Dec 31, 2021 1.45 Mn
Dec 31, 2020 4.83 Mn
Dec 31, 2020 4.83 Mn
Dec 31, 2019 944,000.00
Dec 31, 2019 944,000.00
Dec 31, 2018 731,000.00
Dec 31, 2018 731,000.00
Dec 31, 2017 1.80 Mn
Dec 31, 2017 1.80 Mn
Dec 31, 2016 62,921.00
Dec 31, 2016 62,921.00